RPRX icon

Royalty Pharma
RPRX

Overview Fund Activity

375 hedge funds and large institutions have $8.33B invested in Royalty Pharma in 2024 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 139 increasing their positions, 127 reducing their positions, and 56 closing their positions.

Holders
375
Holders Change
-1
Holders Change %
-0.27%
% of All Funds
5.46%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
59
Increased
139
Reduced
127
Closed
56
Calls
$13.5M
Puts
$4.19M
Net Calls
+$9.31M
Net Calls Change
+$4.69M

Top Buyers

1
Swedbank
1
Swedbank
Sweden
$285M
2
BlackRock
2
BlackRock
New York
$607M
3
BGIM
3
Brandywine Global Investment Management
Pennsylvania
$43.2M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$39.4M
5
Invesco
5
Invesco
Georgia
$45.8M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$735M
2
Manulife (Manufacturers Life Insurance)
2
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$7.38M
3
Millennium Management
3
Millennium Management
New York
$62M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$0
5
CSS
5
Cubist Systematic Strategies
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SCM
26
Suvretta Capital Management
New York
$49.2M 1,866,361 -384,000 -17%
HA
27
Homestead Advisers
Virginia
$49M 1,859,940 -32,600 -2%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$48.5M 1,837,338 -297,566 -14%
Mitsubishi UFJ Trust & Banking
29
Mitsubishi UFJ Trust & Banking
Japan
$48.3M 1,830,867 -26,131 -1%
Janus Henderson Group
30
Janus Henderson Group
United Kingdom
$46.6M 1,767,417 -85,243 -5%
Invesco
31
Invesco
Georgia
$45.8M 1,736,521 +1,062,833 +158%
Qube Research & Technologies (QRT)
32
Qube Research & Technologies (QRT)
United Kingdom
$44.3M 1,679,135 +908,455 +118%
BGIM
33
Brandywine Global Investment Management
Pennsylvania
$43.2M 1,637,195 +1,637,195 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$40.4M 1,533,094 +86,248 +6%
GA
35
General Atlantic
New York
$39.6M 1,500,000 – –
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$39.4M 1,495,358 +1,063,108 +246%
PCM
37
Patient Capital Management
Maryland
$37.6M 1,424,390 +4,572 +0.3%
Franklin Resources
38
Franklin Resources
California
$36.7M 1,390,385 +165,012 +13%
AllianceBernstein
39
AllianceBernstein
Tennessee
$34.6M 1,310,876 -133,640 -9%
UBS Group
40
UBS Group
Switzerland
$33.9M 1,285,120 +585,185 +84%
Aberdeen Group
41
Aberdeen Group
United Kingdom
$31.3M 1,188,009 -110,391 -9%
ACM
42
ADAR1 Capital Management
Texas
$31.2M 1,181,332 +460,031 +64%
RP
43
Regal Partners
Australia
$31.1M 1,177,601 +217,774 +23%
Swiss National Bank
44
Swiss National Bank
Switzerland
$29.6M 1,123,600 -13,400 -1%
Man Group
45
Man Group
United Kingdom
$26.6M 1,010,468 +813,343 +413%
Sumitomo Mitsui Trust Group
46
Sumitomo Mitsui Trust Group
Japan
$26.2M 993,578 +62,218 +7%
Deutsche Bank
47
Deutsche Bank
Germany
$25.8M 979,784 +410,590 +72%
Marshall Wace
48
Marshall Wace
United Kingdom
$24.9M 945,840 -510,060 -35%
Arrowstreet Capital
49
Arrowstreet Capital
Massachusetts
$24.8M 940,034 +57,288 +6%
Nuveen Asset Management
50
Nuveen Asset Management
Illinois
$24.6M 932,441 -45,265 -5%
1
2
3 4 5